Can stopping gabapentin (Neurontin) cause itching (pruritus)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Stopping Gabapentin Cause Itching?

Yes, stopping gabapentin abruptly can cause itching as part of a withdrawal syndrome. The FDA drug label for Neurontin (gabapentin) explicitly documents that "adverse events following the abrupt discontinuation of gabapentin have also been reported," with anxiety, insomnia, nausea, pain, and sweating being the most frequently reported withdrawal symptoms 1. While itching/pruritus is not specifically listed among the most common withdrawal effects in the FDA label, the medication guide emphasizes that "stopping NEURONTIN suddenly can cause serious problems" and warns patients to never discontinue without first consulting their healthcare provider 1.

Understanding the Paradox

This creates an important clinical paradox: gabapentin is actually used to treat pruritus in multiple conditions, including uremic pruritus, neuropathic itch, and drug-induced pruritus 2, 3. Recent meta-analyses confirm gabapentin's efficacy in reducing pruritus severity across various etiologies 4, 5. However, when the medication is stopped suddenly, rebound phenomena can occur.

Clinical Mechanism

The mechanism likely involves:

  • Rebound neuronal hyperexcitability when GABA-ergic modulation is abruptly withdrawn
  • Unmasking of underlying pruritic conditions that were being suppressed by gabapentin
  • Withdrawal-related autonomic dysregulation affecting cutaneous nerve fibers

Management Approach

If a patient develops itching after stopping gabapentin:

  1. Determine if this represents true withdrawal (onset within days of discontinuation) versus unmasking of an underlying condition that gabapentin was treating

  2. For withdrawal-related itching:

    • Consider restarting gabapentin at a low dose and tapering gradually over 1-2 weeks rather than abrupt cessation
    • The FDA label explicitly warns against sudden discontinuation 1
  3. Symptomatic management during taper:

    • H1-antihistamines (fexofenadine 180 mg or cetirizine 10 mg) 3
    • Emollients for skin barrier support 3
    • Consider short-term topical corticosteroids if severe
  4. Taper schedule (adjust based on original dose):

    • Reduce by 25% every 3-7 days
    • For patients on higher doses (>900 mg/day), slower tapers may be necessary
    • Monitor for other withdrawal symptoms (anxiety, insomnia, pain)

Critical Caveats

  • Never abruptly discontinue gabapentin, especially in patients with epilepsy, as this can precipitate status epilepticus 1
  • Patients with renal impairment require even more gradual tapers due to prolonged drug elimination
  • If itching persists beyond 2 weeks after complete discontinuation, investigate alternative causes of pruritus rather than attributing it solely to withdrawal

The evidence strongly supports that gabapentin discontinuation should always be gradual and supervised, with awareness that withdrawal symptoms including potentially itching can occur with abrupt cessation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.